Martin Mück-Häusl - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Nucleic Acids Research|January 23, 2015

Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenovirusesMartin Mück-Häusl, Manish Solanki, Wenli Zhang, et al.

Vaccines|August 28, 2021

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV InfectionAnna D Kosinska, Julia Festag, Martin Mück-Häusl, et al.

Vaccines|February 28, 2023

Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in MiceAnn-Sophie Stephan, Anna D Kosinska, Martin Mück-Häusl, et al.

Plos One|April 25, 2014

Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffoldsMichael Behr, Johanna K Kaufmann, Patrick Ketzer, et al.

Nature Communications|September 16, 2025

A mesothelial differentiation gateway drives fibrosisSafwen Kadri, Adrian Fischer, Martin Mück-Häusl, et al.

Nature Immunology|March 31, 2022

Neutrophils direct preexisting matrix to initiate repair in damaged tissuesAdrian Fischer, Juliane Wannemacher, Simon Christ, et al.

Nature Communications|November 7, 2020

Injury triggers fascia fibroblast collective cell migration to drive scar formation through N-cadherinDongsheng Jiang, Simon Christ, Donovan Correa-Gallegos, et al.

Molecular Therapy. Nucleic Acids|August 13, 2025

MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccinationAnna D Kosinska, Martin Kächele, Helene A Kerth, et al.

Medrxiv : the Preprint Server for Health Sciences|February 6, 2026

Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodiesAnna Semenova, Taylor A Poor, Johannes B Müller-Reif, et al.

JCI Insight|June 8, 2026

Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodiesAnna Semenova, Taylor A Poor, Johannes B Müller-Reif, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Nucleic Acids Research|January 23, 2015

Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenovirusesMartin Mück-Häusl, Manish Solanki, Wenli Zhang, et al.

Vaccines|August 28, 2021

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV InfectionAnna D Kosinska, Julia Festag, Martin Mück-Häusl, et al.

Vaccines|February 28, 2023

Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in MiceAnn-Sophie Stephan, Anna D Kosinska, Martin Mück-Häusl, et al.

Plos One|April 25, 2014

Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffoldsMichael Behr, Johanna K Kaufmann, Patrick Ketzer, et al.

Nature Communications|September 16, 2025

A mesothelial differentiation gateway drives fibrosisSafwen Kadri, Adrian Fischer, Martin Mück-Häusl, et al.

Nature Immunology|March 31, 2022

Neutrophils direct preexisting matrix to initiate repair in damaged tissuesAdrian Fischer, Juliane Wannemacher, Simon Christ, et al.

Nature Communications|November 7, 2020

Injury triggers fascia fibroblast collective cell migration to drive scar formation through N-cadherinDongsheng Jiang, Simon Christ, Donovan Correa-Gallegos, et al.

Molecular Therapy. Nucleic Acids|August 13, 2025

MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccinationAnna D Kosinska, Martin Kächele, Helene A Kerth, et al.

Medrxiv : the Preprint Server for Health Sciences|February 6, 2026

Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodiesAnna Semenova, Taylor A Poor, Johannes B Müller-Reif, et al.

JCI Insight|June 8, 2026

Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodiesAnna Semenova, Taylor A Poor, Johannes B Müller-Reif, et al.

Pageof 2